Increased Risk of Both Ulcerative Colitis and Crohn’s Disease in a Population Suffering from COPD
✍ Scribed by Anders Ekbom; Lena Brandt; Fredrik Granath; Claes-Göran Löfdahl; Arne Egesten
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 165 KB
- Volume
- 186
- Category
- Article
- ISSN
- 0341-2040
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background: Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory diseases of the digestive tract. Genetic factors and an abnormal immune response to infections are suspected to be involved in inflammatory bowel diseases. ## Methods: In the present study 300 blood samples from
## Background: The published experience regarding the use of tacrolimus in crohn's disease (cd) and ulcerative colitis (uc) refractory to more commonly used medical therapy has been fairly limited. our objective was to describe our experience with its use in a cohort of patients which, to our knowl
Ulcerative colitis (UC) and, to a lesser extent, Crohn's disease (CD) are associated with a reduction of the protective mucus layer in the large intestine; the role of this alteration in the pathogenesis of either disease is, however, not clear. To learn more about the molecular mechanism of the alt
The occurrence of Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL) appearing in the same individual indicates a closer relationship between the 2 diseases than previously believed. The purpose of our study was to analyze cases of HD and NHL in a defined population clinically, histopathologica
Background: HLA-G antigens are nonclassical major histocompatibility complex (MHC) class I molecules characterized by tolerogenic and antiinflammatory properties. Recently, a different expression of HLA-G antigens has been observed between intestinal biopsies of ulcerative colitis (UC) and Crohn's d